Chinese biotech Minghui Pharmaceutical has sold certain rights to its experimental cancer drug MHB088C to Qilu Pharmaceutical ...

Swiss pharma giant Roche is investing $280 million to build a new biopharma manufacturing facility in Shanghai, as it doubles ...

Spanish dermatology specialist Almirall was the envy of investors on Monday, with its share price closing 10% higher.

Japanese drugmaker Shionogi (TYO: 4507) has entered into a joint research agreement with French firm Cilcare for the creation ...

US healthcare giant Johnson & Johnson has announced new data from the Phase III ICONIC-TOTAL study investigating icotrokinra ...

Boston, USA-based biotech Aera Therapeutics, which is harnessing next-generation enabling delivery technologies and precision ...

The UK’s BioIndustry Association (BIA) has publishes its 10-year Vision for the UK life science sector called “A Vision for ...

US pharma major Eli Lilly (NYSE: LLY) announced a significant expansion of its long-standing alliance with Purdue University, ...

Denmark, oncology-based Pharmacosmos today announced that it has assumed the worldwide rights, excluding select Asia-Pacific ...

N) today presented data from the Phase III REAL8 basket study, which showed that once-weekly Sogroya (somapacitan) was ...

Shine Technologies, a private nuclear fusion corporation based in Wisconsin, USA, has entered into a definitive agreement to ...

UK-based pharma major AstraZeneca (LSE: AZN) has started construction on a new manufacturing site for small molecule drugs in ...